Full notification file
Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Development of a vaccine against feline rabies. Experiment outside containment (clinical trial) for the study of the safety and the efficacy of a subcutaneous administration of a recombinant canarypoxvirus expressing the surface glycoprotein G gene from Rabies virus (vCP65).
Proposed period of release:
01/05/2006 to 31/12/2006
Name of the Institute(s) or Company(ies)
Merial Laboratoires, 17, rue Bourgelat
3. Is the same GMO release planned elsewhere in the Community?
Has the same GMO been notified elsewhere by the same notifier?
GMO is a:
Identity of the GMO:
vCP65 consisting of a recombinant canarypox virus expressing the surface glycoprotein G gene from Rabies virus, under control of the H6 promoter from the vaccinia virus.
Information relating to the recipient or parental organisms from wich the GMO is derived
strain of the KANAPOX vaccine
European Commission administrative information
Consent given by the Member State Competent Authority: